ID: ALA1800873

Max Phase: Preclinical

Molecular Formula: C6H9N3O5S

Molecular Weight: 235.22

Molecule Type: Small molecule

Representations

Canonical SMILES:  NC(=O)N1CC[C@@H]2[C@H]1C(=O)N2S(=O)(=O)O

Standard InChI:  InChI=1S/C6H9N3O5S/c7-6(11)8-2-1-3-4(8)5(10)9(3)15(12,13)14/h3-4H,1-2H2,(H2,7,11)(H,12,13,14)/t3-,4+/m1/s1

Standard InChI Key:  WOZXBMRGQVWNEP-DMTCNVIQSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 235.22

Molecular Weight (Monoisotopic): 235.0263

AlogP: -1.85

#Rotatable Bonds: 1

Polar Surface Area: 121.01

Molecular Species: ACID

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: -1.38

CX Basic pKa:

CX LogP: -3.83

CX LogD: -4.81

Aromatic Rings: 0

Heavy Atoms: 15

QED Weighted: 0.41

Np Likeness Score: -0.16

References

1. Chen H, Blizzard TA, Kim S, Wu J, Young K, Park YW, Ogawa AM, Raghoobar S, Painter RE, Wisniewski D, Hairston N, Fitzgerald P, Sharma N, Scapin G, Lu J, Hermes J, Hammond ML..  (2011)  Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.,  21  (14): [PMID:21676616] [10.1016/j.bmcl.2011.05.065]

Source

Source(1):

• Scientific Literature